These novel medications , Semaglutide , represent a remarkable advancement in managing metabolic dysfunction and potentially other conditions . They are categorized as GLP-1 hormone activators , meaning they function to replicate the endogenous GLP-1 substance , enhancing metabolic release and suppressing appetite . Although Tirzepatide every funct